Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for ...

Novo Nordisk CEO Lars Fruergaard Jorgensen will testify Tuesday before a Senate panel looking into the drug maker's pricing ...

Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO is ...

Lars Fruergaard Jørgensen, Novo Nordisk's CEO, says his company is working to expand manufacturing to meet the supply ...

Novo Nordisk chief executive Lars Fruergaard Jørgensen faced questioning on Capitol Hill over the health care costs of the ...

The CEO of Novo Nordisk is set to face pointed questions on Capitol Hill Tuesday about the prices of the Danish ...

For the millions of people living with diabetes or obesity, drugs like Ozempic and Wegovy can significantly improve their ...

In Senator Bernie Sanders's letter to chief executive Lars Fruergaard Jørgensen, he says drugmaker Novo Nordisk charges $969 ...

Novo Nordisk CEO grilled over company's pricing for the diabetes drug Ozempic and the weight-loss drug Wegovy.

智通财经APP注意到，Ozempic 和 Wegovy 为 诺和诺德 (NVO.US)公司赚取了巨额利润，它们的累计销售额很快就会超过这家制药商过去 30 年的全部研发预算。而 ...

Ozempic and Wegovy are some of the most popular drugs in the country, driven by their remarkable success in treating diabetes ...

智通财经注意到，Ozempic 和 Wegovy 为诺和诺德（NVO.US）公司赚取了巨额利润，它们的累计销售额很快就会超过这家制药商过去 30 ...